CHURCH KEVIN
Insider CIK 1822499 · ATHA Vice President of Discovery
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LONA LeonaBio, Inc. | A Award deriv | 2026-04-09 | 2026-04-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| LONA LeonaBio, Inc. | S Sale | 2026-03-04 | 2026-03-05 | 1,359 | $5.37 | $7.3K | 25,178 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise deriv | 2026-03-03 | 2026-03-05 | 5,856 | — | $0 | 0 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise | 2026-03-03 | 2026-03-05 | 5,856 | — | $0 | 26,537 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2026-01-02 | 2026-01-05 | 876 | $6.88 | $6.0K | 20,681 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 3,667 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 3,667 | — | $0 | 21,557 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-24 | 2025-12-29 | 35,138 | — | $0 | 35,138 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2025-11-18 | 2026-01-05 | 1,000 | $2.31 | $2.3K | 17,890 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-02 | 8,526 | $0.29 | $2.5K | 168,901 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-06-30 | 2025-07-02 | 36,666 | — | $0 | 36,667 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-06-30 | 2025-07-02 | 36,666 | — | $0 | 177,427 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2025-05-19 | 2025-07-02 | 10,000 | $0.23 | $2.3K | 140,761 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 58,563 | — | $0 | 58,563 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 87,845 | — | $0 | 87,845 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 8,510 | $0.56 | $4.8K | 130,761 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 36,667 | — | $0 | 73,333 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 36,667 | — | $0 | 139,271 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-11-18 | 2025-01-03 | 9,920 | $0.55 | $5.5K | 102,604 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-09-05 | 2024-09-05 | 2,525 | $0.57 | $1.4K | 92,684 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-09-03 | 2024-09-05 | 10,000 | — | $0 | 95,209 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-05-20 | 2024-09-05 | 4,953 | $1.34 | $6.6K | 85,209 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 220,000 | — | $0 | 220,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-01-05 | 2024-02-16 | 2,412 | $2.91 | $7.0K | 80,256 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-01-04 | 2024-02-16 | 10,000 | — | $0 | 82,668 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2023-11-20 | 2024-01-08 | 3,397 | $1.34 | $4.6K | 72,668 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2023-11-20 | 2024-02-16 | 3,397 | $1.34 | $4.6K | 72,668 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2023-05-18 | 2024-01-08 | 809 | $2.41 | $1.9K | 69,271 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2023-05-18 | 2024-02-16 | 809 | $2.41 | $1.9K | 69,271 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2023-03-24 | 2023-03-27 | 6,410 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2023-03-24 | 2023-03-27 | 6,410 | $1.35 | $8.7K | 68,462 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2023-01-19 | 2023-01-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2023-01-05 | 2024-01-08 | 2,412 | $2.91 | $7.0K | 80,256 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2023-01-04 | 2024-01-08 | 10,000 | — | $0 | 82,668 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-11-18 | 2023-01-23 | 657 | $2.74 | $1.8K | 62,052 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2022-10-28 | 2022-10-31 | 3,700 | — | $0 | 6,410 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2022-10-28 | 2022-10-31 | 3,700 | $1.35 | $5.0K | 61,395 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2022-06-23 | 2022-06-24 | 2,614 | $2.69 | $7.0K | 57,695 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-06-22 | 2022-06-24 | 10,000 | — | $0 | 60,309 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2022-06-08 | 2022-06-10 | 2,500 | — | $0 | 10,110 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2022-06-08 | 2022-06-10 | 2,500 | $1.35 | $3.4K | 50,309 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-05-18 | 2022-06-10 | 243 | $7.06 | $1.7K | 47,809 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2022-02-18 | 2022-02-18 | 3,152 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2022-02-18 | 2022-02-18 | 3,152 | $1.19 | $3.8K | 47,566 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2021-11-18 | 2022-01-20 | 96 | $12.51 | $1.2K | 44,414 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2021-06-08 | 2021-06-09 | 3,152 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2021-06-08 | 2021-06-10 | 3,152 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2021-06-08 | 2021-06-09 | 3,152 | $1.04 | $3.3K | 44,133 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2021-06-08 | 2021-06-10 | 3,152 | $1.04 | $3.3K | 44,318 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2021-05-18 | 2021-06-10 | 185 | $14.45 | $2.7K | 41,166 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2021-02-18 | 2021-02-22 | 20,000 | — | $0 | 20,000 | SEC↗ |